PALI
Pharmaceuticals, Biotechnology & Life Sciences
CROWD: GREEN
Quiet institutional ownership. No unusual crowd behavior in the latest filings.
Active holders
47
of 96 total, index funds excluded
Conviction
6 bps
median holder weight: token bet
Streak
2q
consecutive rising quarters
The crowd, 2016 to now
active holders per quarter
2021Mar 2026
Holdings as of Mar 31, 2026, filed by May 16, 2026. Counts for the newest quarter keep settling for a few weeks as amendments land.
The tide
funds in (up) vs out (down)
Top holders
by reported value · $257M held
| Fund | Value | Note |
|---|
| B Group, Inc. |
$20M |
|
| JANUS HENDERSON GROUP PLC |
$19M |
|
| Octagon Capital Advisors LP |
$18M |
|
| PERCEPTIVE ADVISORS LLC |
$16M |
|
| AMERIPRISE FINANCIAL INC |
$15M |
|
| Commodore Capital LP |
$13M |
|
| RA CAPITAL MANAGEMENT, L.P. |
$12M |
|
| FRANKLIN RESOURCES INC |
$10M |
|
| GOLDMAN SACHS GROUP INC |
$9M |
|
| Eversept Partners, LP |
$9M |
|
Tourists vs true believers
every holder a dot · right = bigger bet in their own book, up = patient money
Hover any dot for the fund and its bet size. Patience is measured from each filer's actual quarter-to-quarter turnover across our whole database.